Literature DB >> 30025395

Midazolam Enhances Mutant Huntingtin Protein Accumulation via Impairment of Autophagic Degradation In Vitro.

Jiqian Zhang1, Wei Dai1, Pengcheng Geng1, Li Zhang2, Qilian Tan1, Dan Cheng1, Pengfei Wei3, Zhilai Yang1, Lei Zhang1, Erwei Gu1, Guanghong Xu1, Chaozhao Liang2, Xuesheng Liu1.   

Abstract

BACKGROUND/AIMS: Autophagy is a well-known pathway to "clean" the misfolded mutant huntingtin protein (mHtt), which plays a considerable role in polyglutamine diseases. To date, there have been few studies of the choice of anesthetic during surgery in patients with polyglutamine diseases and evaluation of the effects and underlying mechanisms of anesthetics in these patients.
METHODS: GFP-Htt (Q74)-PC12 cells, which stably express green fluorescent protein-tagged Htt protein containing 74 glutamine repeating units, were used throughout this study. Cells were treated with 15 μM midazolam and 100 mM trehalose (positive control), and the induction of autophagy and autophagic degradation were assessed by detecting changes in autophagy-related proteins and substrates, and cell viability was assessed using the MTT assay. Overexpression of cathepsin D by plasmid transfection was used to restore midazolam-impaired autophagic degradation.
RESULTS: Midazolam increased intracellular mHtt levels in a time- and dose-dependent manner. Additionally, enhancing or blocking autophagic flux by trehalose or chloroquine could decrease or increase midazolam-induced mHtt elevation, respectively. Midazolam induced autophagy in the mTOR-dependent signaling pathway, but autophagic degradation was impaired, with a continuous rise in p62 and LC3 II levels and decrease in cathepsin D. However, overexpression of cathepsin D reversed the effects of midazolam. Midazolam led to a 20% decrease in GFP-Htt (Q74)-PC12 cell viability, which could be abrogated by overexpression of cathepsin D.
CONCLUSIONS: Midazolam increased mHtt levels and decreased Htt (Q74)-PC12 cell viability via impairment of autophagic degradation, which could be restored by overexpression of cathepsin D.
© 2018 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Autophagy; Cathepsin D; Midazolam; Mutant huntingtin protein (mHtt); Polyglutamine diseases

Mesh:

Substances:

Year:  2018        PMID: 30025395     DOI: 10.1159/000491895

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  2 in total

1.  Combination therapy with ropivacaine-loaded liposomes and nutrient deprivation for simultaneous cancer therapy and cancer pain relief.

Authors:  Jiqian Zhang; Shasha Zhu; Qilian Tan; Dan Cheng; Qingqing Dai; Zhilai Yang; Lei Zhang; Fenfen Li; Youmei Zuo; Wei Dai; Lihai Chen; Erwei Gu; Guanghong Xu; Zhaolian Wei; Yunxia Cao; Xuesheng Liu
Journal:  Theranostics       Date:  2020-03-26       Impact factor: 11.556

2.  Sufentanil impairs autophagic degradation and inhibits cell migration in NCI-H460 in vitro.

Authors:  Hui Jiang; Hongxian Wang; Weiwei Zou; Yuexia Hu; Chen Chen; Chunhui Wang
Journal:  Oncol Lett       Date:  2019-10-17       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.